Next Article in Journal
Increased E2F1 mRNA and miR-17-5p Expression Is Correlated to Invasiveness and Proliferation of Pituitary Neuroendocrine Tumours
Next Article in Special Issue
Saliva—Friend and Foe in the COVID-19 Outbreak
Previous Article in Journal
Comparative Study Regarding the Properties of Methylene Blue and Proflavine and Their Optimal Concentrations for In Vitro and In Vivo Applications
Previous Article in Special Issue
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends
Open AccessEditorial

Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic

Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu 300, Taiwan
Department of Medical Genetics, Di Venere Hospital, ASL BARI, 701 Bari, Italy
Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan
Authors to whom correspondence should be addressed.
Diagnostics 2020, 10(4), 224;
Received: 13 April 2020 / Revised: 15 April 2020 / Accepted: 15 April 2020 / Published: 16 April 2020
Note: In lieu of an abstract, this is an excerpt from the first page.

The current standard testing method for screening coronavirus disease 2019 (COVID-19) is through reverse real-time PCR assay (rRT-PCR), a common molecular-based assay that requires an average of four to six hours to provide results [...] View Full-Text
Show Figures

Figure 1

MDPI and ACS Style

Yang, T.; Gentile, M.; Shen, C.-F.; Cheng, C.-M. Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic. Diagnostics 2020, 10, 224.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop